Pharmaceutical compositions for the treatment of tumours that express EGFR and ganglioside N-glycolyl GM3 (NEUGCGM3)

The invention relates to pharmaceutical composition for the treatment of malignant tumours, in particular tumours that express EGFR and N-glycolyl GM3 ganglioside targets, in order to enhance the therapeutic effect produced individually by therapies against said targets. The pharmaceutical compositi...

Full description

Saved in:
Bibliographic Details
Main Authors MACIAS ABRAHAM, AMPARO EMILIA, BLANCO SANTANA, RANCES, LEON MONZON, KALET, MONTERO CASIMIRO, JOSE ENRIQUE, CARR PEREZ, ADRIANA, GONZALEZ PALOMO, ADYS, BARROSO ALVAREZ, MARIA DEL CARMEN
Format Patent
LanguageEnglish
Published 19.11.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to pharmaceutical composition for the treatment of malignant tumours, in particular tumours that express EGFR and N-glycolyl GM3 ganglioside targets, in order to enhance the therapeutic effect produced individually by therapies against said targets. The pharmaceutical compositions of the invention comprise antibodies and/or vaccines against each of the targets. In addition, the invention relates to the methods used to apply the compositions of the invention.
Bibliography:Application Number: AU20120361321